Across TCGA pan-cancer cohorts, LINC01389 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01389 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher LINC01389 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01389 expression acts as an unfavorable survival marker, although some lineages such as READ and CHOL show a favorable association.
UVM, KIRC, and LGG are the cancer types where LINC01389 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.